Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 28, 2010

Roche Makes Near $95M Investment in Singapore-Based Center for Translational Medicine

  • Roche is ploughing CHF 100 million (roughly $94.94 million) into the establishment of a Hub for Translational Medicine in Singapore. The company’s vision is to set up a public-private partnership that combines its own expertise in translational medicine and clinical development with the complementary capabilities of Singapore’s network of research and medical institutions.

    The Roche-Singapore Hub for Translational Medicine center will focus on expanding scientific knowledge of disease biology to accelerate the development of personalized treatment approaches. Employing about 30 scientists, the center will be led by a steering committee comprising members from Roche and participating Singapore institutes, which will define strategic directions and oversee research.

    Roche claims Singapore’s research institutions offer outstanding scientific excellence combined with state-of-the-art translational medicine facilities. “The powerful combination of intellectual and technology capabilities together with outstanding government commitment at the heart of this collaboration will provide a unique opportunity to drive personalized healthcare,” claims Jean-Jacques Garaud, global head of Roche pharma research and early development.

    “Leveraging Singapore’s close-knit research community and clinical research infrastructure, companies are well-positioned to develop cost-effective, efficacious therapies more quickly for Asia and global markets,” adds Professor Edward Holmes, M.D., chairman of Singapore’s National Medical Research Council. “Within just one decade, Singapore has emerged as a key partner for leading pharmaceutical and biotech companies that seek to accelerate drug discovery in Asia.”


Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »